Entero Therapeutics, Inc. (ENTO)

NASDAQ: ENTO · IEX Real-Time Price · USD

1.001

+0.011 (1.12%)

At close: Jul 19, 2024, 4:00 PM

0.999

-0.002 (-0.17%)

Pre-market: Jul 22, 2024, 8:04 AM EDT

Entero Therapeutics Employees

Entero Therapeutics had 9 employees as of December 31, 2023. The number of employees decreased by 1 or -10.00% compared to the previous year.

Employees

Change (1Y)

-1

Growth (1Y)

-10.00%

Revenue / Employee

n/a

Profits / Employee

-$715,952

Market Cap

2.48M

Employees Chart

Date	Employees	Change	Growth
Dec 31, 2023	9	-1	-10.00%
Dec 31, 2022	10	-7	-41.18%
Dec 31, 2021	17	5	41.67%
Dec 31, 2020	12	2	20.00%
Dec 31, 2019	10	-2	-16.67%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Company Name	Employees
ASLAN Pharmaceuticals	35
FOXO Technologies	29
Helius Medical Technologies	22
Tenon Medical	21
Catheter Precision	14
Cyclacel Pharmaceuticals	12
Heart Test Laboratories	12
Altamira Therapeutics	10